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IMPORTANCE Many patients with acute low back pain do not recover with basic first-line care
(advice, reassurance, and simple analgesia, if necessary). It is unclear whether intensive
patient education improves clinical outcomes for those patients already receiving first-line
care.
OBJECTIVE To determine the effectiveness of intensive patient education for patients with
acute low back pain.
DESIGN, SETTING, AND PARTICIPANTS This randomized, placebo-controlled clinical trial
recruited patients from general practices, physiotherapy clinics, and a research center in
Sydney, Australia, between September 10, 2013, and December 2, 2015. Trial follow-up was
completed in December 17, 2016. Primary care practitioners invited 618 patients presenting
with acute low back pain to participate. Researchers excluded 416 potential participants. All
of the 202 eligible participants had low back pain of fewer than 6 weeks’ duration and a high
risk of developing chronic low back pain according to Predicting the Inception of Chronic Pain
(PICKUP) Tool, a validated prognostic model. Participants were randomized in a 1:1 ratio to
either patient education or placebo patient education.
INTERVENTIONS All participants received recommended first-line care for acute low back pain
from their usual practitioner. Participants received additional 2 × 1-hour sessions of patient
education (information on pain and biopsychosocial contributors plus self-management
techniques, such as remaining active and pacing) or placebo patient education (active
listening, without information or advice).
MAIN OUTCOMES AND MEASURES The primary outcome was pain intensity (11-point numeric
rating scale) at 3 months. Secondary outcomes included disability (24-point Roland Morris
Disability Questionnaire) at 1 week, and at 3, 6, and 12 months.
RESULTS Of 202 participants randomized for the trial, the mean (SD) age of participants was
45 (14.5) years and 103 (51.0%) were female. Retention rates were greater than 90% at all
time points. Intensive patient education was not more effective than placebo patient
education at reducing pain intensity (3-month mean [SD] pain intensity: 2.1 [2.4] vs 2.4 [2.2];
mean difference at 3 months, –0.3 [95% CI, –1.0 to 0.3]). There was a small effect of intensive
patient education on the secondary outcome of disability at 1 week (mean difference, –1.6
points on a 24-point scale [95% CI, –3.1 to –0.1]) and 3 months (mean difference, –1.7 points,
[95% CI, –3.2 to –0.2]) but not at 6 or 12 months.
CONCLUSIONS AND RELEVANCE Adding 2 hours of patient education to recommended
first-line care for patients with acute low back pain did not improve pain outcomes. Clinical
guideline recommendations to provide complex and intensive support to high-risk patients
with acute low back pain may have been premature.
TRIAL REGISTRATION Australian Clinical Trial Registration Number: 12612001180808
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F or the past 5 years, the Global Burden of Disease Study1has consistently ranked low back pain as the leadingcause of disability worldwide. Low back pain is second
only to the common cold as a reason for consulting a general
practitioner.2 A recent international review highlighted a global
crisis in the mismanagement of low back pain, with high rates
of guideline-discordant care in both high- and low-middle in-
come countries.3-5 In their call to action, the Lancet Low Back
Pain Series Working Group authors recommended that re-
searchers and policy makers: “Develop and implement strat-
egies to ensure early identification and adequate education of
patients with low back pain at risk for persistence of pain and
disability.”3-5
To manage uncomplicated acute low back pain (fewer than
6 weeks of pain duration), international guidelines recom-
mend that general practitioners provide advice, education, re-
assurance, and simple analgesics, if necessary.6 Although many
patients receiving this care improve rapidly, 33% experience
a recurrence in the next 12 months7 and 20% to 30% develop
chronic pain (defined as pain duration of 3 months or more).8
Patients who are at high risk of pain chronicity may require
additional care, including second-line options such as physical
(eg, spinal manipulation) and/or psychological therapies (eg, psy-
chologically informed physiotherapy).6 However, most trials that
haveevaluatedaddingsecond-linetreatmentoptionstostandard
guideline care for patients with acute low back pain have failed
to demonstrate effectiveness compared with placebo (eg, addi-
tionofspinalmanipulation,nonsteroidalantiinflammatorydrugs,
or both9; addition of structured exercises10; and addition of acu-
puncture, massage, or chiropractic care11). Patient education, a
treatment that authors of a 2008 Cochrane review12 concluded
was effective for acute low back pain when applied in an inten-
sive format and that every major clinical guideline recommends
(but with little instruction on intensity),13 has never been tested
in a placebo-controlled trial. Any benefits observed in previous
trials of patient education for acute low back pain could be ex-
plainedbynonspecificeffectsoftheclinicalencounterorthechar-
acteristics of the usual care comparison.
Pain education, a form of intensive patient education that
is often included in pain management programs, requires up to
2 hours during several encounters with a trained health practi-
tioner. It involves detailed discussion of pain, including psycho-
social contributors and advice about pacing and activity. Trials
have found clinically meaningful effects of pain education on
pain and disability in samples of patients with chronic pain.14
It is unknown whether intensive patient education, in addi-
tion to recommended first-line care, can improve outcomes for
patients with acute low back pain. To address this gap in the lit-
erature, we conducted, to our knowledge, the first randomized,
placebo-controlled trial of patient education for acute low back
pain (Preventing Chronic Low Back Pain [PREVENT] Trial).15
Methods
Study Design
This was an assessor-blinded, 1:1 parallel group, randomized,
placebo-controlled trial. We published a study protocol prior
to enrolling participants15 (the original trial protocol is avail-
able in Supplement 1). The trial was prospectively registered.
The University of New South Wales Human Research Ethics
Committee, Sydney, New South Wales, Australia, approved the
study on February 5, 2013 (reference number: HC12664). We
obtained written, informed consent from all participants be-
fore they enrolled in the trial.
Treatments took place at physiotherapy clinics, general
practices, or clinic rooms at a research institute (Neurosci-
ence Research Australia) in Sydney, Australia. One of 2 trial cli-
nicians (A.C.T. and I.W.S.) provided the treatment at partici-
pating centers. We recruited participants between September
10, 2013, and December 2, 2015. Trial follow-up was com-
pleted on December 17, 2016.
Participants
We sought to recruit participants aged 18 to 75 years who were
seeking care for acute low back pain with or without referred
leg pain. Participants with signs of radiculopathy (spinal nerve
root compromise) were included. All participants were re-
ferred from general practitioners or physiotherapists. We ex-
cluded potential participants if they had the following: (1)
chronic low back pain (more than 1 on a 11-point pain inten-
sity numeric rating scale for more than 3 months), (2) less than
3 of 10 on the pain intensity numeric rating scale over the past
week, (3) low risk of pain chronicity (less than 30% absolute
risk of chronic pain according to the Predicting Inception of
Chronic Pain (PICKUP) Tool8 [eMethods 1 in Supplement 2]),
(4) clinical features of serious spinal pathology (eg, cauda
equina syndrome, infection, fracture, or cancer) assessed by
a clinician, (5) poor command of the English language, (6) pre-
vious spinal surgery, or (7) a mental health condition that would
preclude study participation. Referring clinicians were trained
to provide all recruited participants with guideline-based care
(advice to stay active, avoid bed rest, option of spinal manipu-
lation, and/or simple analgesics). Staff were reimbursed per par-
ticipant recruited for time spent on the study.
Randomization and Masking
We randomized participants in a 1:1 ratio to either intensive pa-
tient education or placebo patient education. The allocation
schedule was generated by a researcher not involved in any
other aspect of the study. That researcher used a computer-
ized random number table to generate the allocation se-
quence in random block sizes of 4, 6, 8, and 10. The same re-
Key Points
Question Is intensive patient education effective as part of
first-line care for patients with acute low back pain?
Findings In this randomized clinical trial of 202 adults with acute
low back pain from Sydney, Australia, adding intensive patient
education to first-line care of patients was no better at improving
pain outcomes than a placebo intervention.
Meaning Intensive patient education should not be offered to
patients with acute low back pain who are receiving first-line care.
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searcher who generated the allocation sequence placed
allocation codes into sequentially numbered, sealed, opaque
envelopes.
Before randomization, all participants completed base-
line data collection and received a standardized short history
and physical examination (approximately 10-minute length)
with the trial clinicians (A.C.T. and I.W.S.). The short history
and physical examination were standardized using pro forma
documents (eMethods 2 in Supplement 2). The trial clini-
cians opened the envelope containing the group allocation. The
allocation was concealed from participants, referring clini-
cians, other trial staff, and outcome assessors.
Alltreatmentwasprovidedduringtheacutephaseoflowback
pain within 6 weeks of pain onset. Each participant received 2 ×
1–hour individual, face-to-face sessions of either patient educa-
tion or placebo patient education. The trial clinicians (A.C.T. and
I.W.S.)whoprovidedthepatienteducationsessionswerethesame
clinicians who provided the placebo patient education. An expert
in pain education (G.L.M.) trained both trial clinicians to deliver
the patient education intervention. An expert clinical psycholo-
gist in pain management (M.K.N.) trained both trial clinicians in
the placebo patient education intervention. Training for the pa-
tient education intervention took approximately 16 hours, with
6 to 8 hours allocated for practicing role-play scenarios. Training
fortheplacebopatienteducationtookapproximately4hoursand
was supplemented with 4 online 45-minute videos demonstrat-
ing techniques for providing a credible consultation that did not
include advice or education.
Interventions
Intensive Patient Education
We adapted the information and advice provided in the pa-
tient education group from the book Explain Pain,16 a text typi-
cally used for people with chronic pain. The intervention is de-
scribed in full and according to the template for intervention
description and replication (TIDieR) checklist in eMethods 3
in Supplement 2. In short, participants in the patient educa-
tion group were provided with a detailed explanation about
the biopsychosocial nature of pain in the format of diagrams,
metaphors, and stories. The patient education intervention in-
volved 3 main components: (1) reframing unhelpful beliefs
about low back pain, (2) presenting information about the bio-
logic basis and protective nature of both acute and chronic low
back pain, and (3) evaluating understanding of new concepts
and discussing techniques to promote recovery. Content was
tailored to the individual according to specific concerns (eg,
“I am worried I will have this back problem forever”) and
misconceptions (eg, “I can’t work because my back is perma-
nently damaged”) that participants expressed during the con-
sultation. Trial clinicians encouraged all participants to self-
manage their low back pain by remaining active and avoiding
bed rest. Trial clinicians also instructed participants on be-
havioral therapy techniques such as pacing.
Placebo Patient Education
We designed the placebo patient education sessions to con-
trol for time with an expert clinician. The sessions mimicked
all aspects of the patient education sessions (listening, show-
ing interest, and attention of the clinician) but without the edu-
cation component. Participants in the placebo patient educa-
tion group received no information, advice, or education about
low back pain from the trial clinician. Participants were en-
couraged to talk about any topic that they desired. Trial clini-
cian responses were aimed to maintain the discussion for the
duration of the session. We included additional detail on the
placebo intervention in eMethods 4 in Supplement 2.
Outcomes and Measurements
We collected self-reported data from participants at baseline (the
first interventionsession);1weekafterthe2interventionsessions
were complete; and 3, 6, and 12 months after the date of low back
pain onset. Participants used online forms to complete outcome
assessments.Baselinedataincludedage,sex,durationofepisode,
number of previous episodes, other painful areas, and work sta-
tus.Anassessorwhowasmaskedtotreatmentallocationarranged
the collection of outcome data using online forms. Participants
completed the credibility and expectancy questionnaire17 in pa-
per format immediately after the trial clinician explained the
rationaleforthestudyandbeforerandomization.Trialstaffmoni-
tored adherence to the 2 intervention sessions using a study cal-
endar. The trial clinician audio recorded all intervention sessions,
with the participants’ verbal consent, to monitor treatment fidel-
ity. Treatment fidelity was evaluated by 2 researchers (G.L.M. and
M.K.N.),wholistenedtothefirstandsecondsessionsfrom10ran-
domlyselectedparticipantsandjudgedwhetherthesessionswere
patient education or placebo patient education. We used κ to de-
termine agreement.
The primary outcome was mean pain intensity during the
past week (reported on an 11-point pain intensity numeric rat-
ing scale), assessed 3 months after the onset of low back pain.
Secondary outcomes and process measures are described in
eMethods 5 of Supplement 2.
Statistical Analysis
We published our statistical analysis plan before analyzing our
results.18 A sample of 202 participants was required to ensure
80% power to detect a mean difference of 1 point on an 11-point
numeric rating scale for pain intensity. Our power calculation as-
sumed an SD of 2.3 and a 2-sided α of .05 and was adjusted with
15% loss to follow-up. We estimated the effect of the interven-
tion on the primary outcome using a mixed model for repeated
measures. We treated time as a categorical variable (1 week and
3, 6, or 12 months) and included group × time interactions to de-
termine treatment effects at each time point. As an exploratory
sensitivity analysis, we calculated P values from mixed models
for repeated measures comparing between-group difference dur-
ing the full 12-month trial, controlling for baseline and includ-
ing all time points as categorical. We determined statistical sig-
nificance to be P < .05 for a 2-sided test. We did not include study
site (physiotherapy practice, general practice, or research insti-
tute) in the model because there was no evidence of site differ-
ences between groups (χ2 test, P = .14). Details of the analysis of
secondary outcomes is provided in eMethods 5 of Supplement
2 and the complete mediation analysis19 in eResults 1 of
Supplement 2. Two authors (S.L. and H.L.) performed the sta-
tistical analyses.
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Results
Between September 10, 2013, and December 2, 2015, we
screened 618 potential participants. Figure 1 shows the flow
of participants through the trial. The main reasons for partici-
pant exclusion included low risk of pain chronicity (n = 146),
chronic pain (n = 79), declined participation (n = 75), or could
not be contacted after initial referral from the primary care prac-
titioner (n = 75). Other reasons for exclusion are shown in
Figure 1. One potential participant was excluded in error be-
cause of pregnancy.
The 2 groups had similar demographic and clinical char-
acteristics at baseline (Table 1). Of 202 participants random-
ized for the trial, 103 (51.0%) were female. Participants were
middle-aged (mean [SD] age, 45.1 [14.5] years), had fewer than
2 weeks of low back pain, and had experienced 3 previous epi-
sodes of low back pain. Physiotherapists referred most par-
ticipants (83%). Half of the sample (52%) felt there was a need
for further investigation of their symptoms. Psychological char-
acteristics were similar between groups; scores for depres-
sion and catastrophizing scales were lower and scores for self-
efficacy were higher than those seen in samples from patients
with chronic pain who attended tertiary care.20
All participants completed both trial sessions. Treatment
credibility scores were not different between groups (mean [SD]
credibility and expectancy questionnaire score for patient edu-
cation vs placebo patient education: 36.6 [8.8] vs 35.3 [10.5];
mean difference, –1.3; 95% CI, –4.0 to 1.4). For our treatment
fidelity check, raters correctly categorized all recordings as pa-
tient education or placebo patient education. There was per-
fect agreement between raters (κ = 1).
The primary analysis (Table 2) showed that patient edu-
cation was not more effective than placebo patient education
at reducing pain intensity at our primary end point (3-month
follow-up mean difference, –0.3 points on an 11-point scale;
95% CI, –1.0 to 0.3; P = .31). Mean (SD) pain intensity de-
creased from 6.3 [2.4] at baseline to 2.1 [2.4] at 3 months in the
patient education group and from 6.1 [2.2] at baseline to 2.4
[2.2] at 3 months in the placebo patient education group.
(Figure 2).
There was a small effect of treatment group on disability,
with patient education lower than placebo patient education
at 1 week (mean difference, –1.6 points on a 24-point scale;
Figure 1. Flowchart of the Preventing Chronic Low Back Pain (PREVENT) Randomized Placebo-Controlled Trial
618 Participants referred from primary care
practitioners and assessed for eligibility
416 Excluded
266 Did not meet inclusion criteria
146 Low risk of pain chronicity
79 Persistent pain
18 Low pain intensity (<3/10)
7 Pain duration >6 wk
6 Previous spinal surgery
5 Age <18 or >75 y
4 Primary pain not in low back
1 Pregnancy
150 Other reasons
75 Could not be contacted
75 Declined
202 Randomized
101 Allocated to two 1-h treatments with patient
education
101 Allocated to two 1-h treatments with placebo
patient education
98 Completed 1-wk follow-up
3 Lost to follow-up (lost contact)
96 Completed 1-wk follow-up
5 Lost to follow-up (lost contact)
97 Completed 3-mo follow-up
4 Lost to follow-up (lost contact)
97 Completed 3-mo follow-up
4 Lost to follow-up (lost contact)
96 Completed 6-mo follow-up
5 Lost to follow-up (lost contact)
95 Completed 6-mo follow-up
6 Lost to follow-up (lost contact)
94 Completed 12-mo follow-up
7 Lost to follow-up (lost contact)
89 Completed 12-mo follow-up
12 Lost to follow-up (lost contact)
101 Included in primary analysis 101 Included in primary analysis
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Table 1. Baseline Characteristicsa
Characteristic Patient Education (n = 101) Placebo Patient Education (n = 101)
Age, mean (SD), y 46.5 (14.7) 43.8 (14.1)
Female sex 53 (52.5) 50 (49.5)
Clinical characteristic
Pain duration, mean (SD), d 12.5 (7.7) 13.5 (8.7)
No. of previous episodes, median (IQR) 3 (5) 3 (7)
No. of other pain sites, mean (SD) 1.0 (1.2) 1.1 (1.3)
Referred by general practitioner 19 (18.8) 16 (15.8)
Referred by physiotherapist 82 (81.2) 85 (84.2)
First episode of back pain 21 (20.8) 18 (17.8)
Pain referred to leg 47 (46.5) 57 (56.4)
Pain in areas other than back or leg 57 (56.4) 55 (54.5)
Work absence or reduced hours 22 (21.8) 31 (30.7)
Receiving pain medication 50 (49.5) 54 (53.5)
Outcome scores at baseline
Pain intensity, mean (SD)b
Week 6.3 (2.4) 6.1 (2.2)
Current 4.0 (2.2) 4.0 (2.3)
Pain interference, mean (SD)c 6.0 (2.5) 6.4 (2.6)
Disability, mean (SD)d 11.0 (5.4) 11.7 (5.8)
Depressive symptoms, mean (SD)e 4.1 (3.7) 5.1 (5.0)
Reassurance
Nothing seriously wrong, mean (SD)f 5.6 (2.7) 5.4 (2.7)
Yes, perceive a need for further tests 51 (50.5) 55 (54.5)
Process measures at baseline, mean (SD)
Neuroscience knowledgeg 6.0 (1.8) 5.9 (1.6)
Pain attitudes: pain is sign of damageh 2.3 (1.2) 2.5 (1.1)
Pain self-efficacyi 35.5 (13.1) 33.1 (13.0)
Catastrophizingj 18.3 (12.0) 19.9 (11.2)
Back beliefsk 27.7 (6.8) 28.3 (6.4)
Abbreviation: IQR, interquartile range.
a Data are presented as number (percentage) of patients unless otherwise
indicated.
b Numeric rating scale with range from 0 (no pain) to 10 (worst pain possible).
c Numeric rating scale with range from 0 (no interference) to 10 (highest
interference possible).
d Roland Morris Disability Questionnaire with range from 0 (no disability) to 24
(high disability).
e Depression severity scale of Depression, Anxiety and Stress Scale with range
from 0 (no depressive symptoms) to 42 (high depressive symptoms).
f“How reassured do you feel that there is no serious condition causing your back
pain?” Range from 0 (not reassured at all) to 10 (completely reassured).
g Neurophysiology of Pain Questionnaire with range from 0 (no knowledge) to
19 (highest knowledge).
h Survey of Pain Attitudes, question 3 from 1-item version: “The pain I feel is a
sign that damage is being done.” Range from 0 (very untrue for me) to 4 (very
true for me).
i Pain Self-Efficacy Questionnaire with range from 0 (low pain self-efficacy) to
60 (high pain self-efficacy).
j Pain Catastrophizing Scale with range from 0 (low catastrophizing) to 52 (high
catastrophizing).
k Back Beliefs Questionnaire with range from 9 (maladaptive or pessimistic
beliefs) to 45 (helpful or positive beliefs).
Table 2. Primary Outcomes for the Patient Education and Placebo Patient Education Groups at 1 Week
and 3, 6, and 12 Months
Variable
Point Estimates, Mean (SD)
Mean Difference
(95% CI) P ValuePatient Education
Placebo Patient
Education
Pain intensity during the
past week
1 wk 3.2 (2.4) 3.1 (2.2) 0.1 (−0.5 to 0.8) .69
3 mo 2.1 (2.4) 2.4 (2.2) −0.3 (−1.0 to 0.3) .31
6 mo 2.3 (2.6) 2.5 (2.3) −0.2 (−0.8 to 0.5) .59
12 mo 1.8 (2.2) 2.5 (2.4) −0.6 (−1.3 to 0.1) .07
Overall intervention
effecta
NA NA NA .26
Abbreviation: NA, not applicable.
a P value is from mixed models for
repeated measures comparing
between-group difference during
the full 12-month trial, controlling
for baseline and including time
points as a categorical variable.
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95% CI, –3.1 to –0.1; P = .03) and at 3 months (mean differ-
ence, –1.7 points; 95% CI, –3.2 to –0.2; P = .03) (Table 3). There
were no between-group differences in disability at 6- or 12-
month follow-up.
There were some significant between-group differences
in secondary outcomes (Table 3). The odds of having a recur-
rence of low back pain at 12 months were lower in the patient
education group than in the placebo patient education group
(odds ratio, 0.44; 95% CI, 0.24-0.82). Pain interference and the
odds of seeking health care were also lower in the patient edu-
cation group at 3 months (pain interference: mean differ-
ence, –0.8; 95% CI, –1.5 to –0.1; P = .02; health care seeking:
odds ratio, 0.43; 95% CI, 0.19-0.93), but results for these vari-
ables were not lower at 6 or 12 months. Pain attitudes and re-
assurance at 1 week were higher in the patient education group
(pain attitudes: mean difference, –0.9; 95% CI, –1.2 to –0.5;
P < .001; reassurance [“How reassured do you feel that there
is no serious condition causing your back pain?”]: mean dif-
ference, 1.2; 95% CI, 0.4-2.0; P = .003), and the effect on pain
attitudes persisted at 12 months.
Patient education was not more effective than placebo pa-
tient education for reducing depressive symptoms, the inci-
dence of chronic low back pain, or global perceived change
(Table 3). The causal mediation analysis confirmed that pa-
tient education reduced catastrophizing and unhelpful be-
liefs (primary treatment targets), but these psychologic mecha-
nisms did not reduce pain intensity (full results of mediation
analysis reported in eResults 1, eTables 1 and 2, and eFigures
1-3 in Supplement 2). There were no reported adverse events
in either treatment group. There was no evidence that out-of-
trial therapy confounded treatment effects (eResults 2 and
eTable 2 in Supplement 2).
Discussion
Our study provides evidence that intensive patient educa-
tion is not effective compared with placebo for patients with
acute low back pain. Two 1-hour sessions of patient educa-
tion were no more effective than a placebo intervention for im-
proving pain at our primary end point of 3 months or at 1 week,
6 months, or 12 months after the onset of acute low back pain.
Disability was significantly lower in the intervention group
compared with the placebo group at 1 week and 3 months but
not at 6 months or 12 months. The short-term effects on dis-
ability, although consistent with those from similar trials,21
were below published guidance on clinically meaningful ef-
fects (2 points on a 24-point Roland Morris Disability Ques-
tionnaire and 1 point on a 10-point numeric rating scale).22 Our
results suggest that offering more intensive patient educa-
tion to patients with acute low back pain than that provided
as part of standard practice does not reduce pain intensity or
lead to meaningful reductions in disability.
Our results challenge a widespread belief that patient edu-
cation is an effective strategy for treatment of acute low back
pain. For example, every clinical guideline recommends pa-
tient education to manage acute low back pain.13 These rec-
ommendations are, however, often unaccompanied by an evi-
dence statement (eg, neither US23 nor UK22 guidelines cite
evidence for patient education) or instruction on how patient
education interventions should be conducted.24 Two system-
atic reviews have concluded that primary care–based patient
education is effective for acute low back pain.12,25 The avail-
able Cochrane review12 of individual patient education in-
cluded 6 trials of patient education compared with usual care:
3 trials of brief interventions (<20 minutes) and 3 trials of in-
tensive interventions (>2 hours). The authors concluded that
intensive patient education may be more effective at increas-
ing return-to-work rates compared with usual care based on
2 trials (n = 1432). However, those trials did not include pain
or disability outcomes. Although a more recent review of 14
trials found that brief patient education could reduce back pain–
related distress (n = 4872),25 it was unclear whether these in-
terventions could improve other clinical outcomes such as
pain.26 Of importance, our mediation analysis (eResults 1 in
Supplement 2) suggests that interventions aimed at reducing
pain-related distress (eg, catastrophization) are unlikely to in-
fluence the pain experience as much as previously thought.
Strengths and Limitations
This trial15 had several strengths. It was the first trial, to our
knowledge, to test a patient education intervention against a
credible placebo (ie, a professional consultation without any
information or advice) in patients with acute low back pain.




































1 wk 3 mo 6 mo 12 mo
Patient education
Placebo patient education
A, Mean pain intensity score (primary
outcome) using a numeric rating scale
ranging from 0 (no pain) to 10 (worst
pain possible). B, Mean disability
outcomes score at 1 week and 3, 6,
and 12 months using the Roland
Morris Disability Questionnaire
ranging from 0 (no disability) to 24
(high disability). Whiskers indicate
95% CIs.
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This strategy allowed us to determine the specific effects of
patient education and control for effects produced by a clini-
cal encounter, for example, those from the attention of a health
professional or from the credibility of an impending treat-
ment. We trained 2 trial clinicians to ensure treatment fidel-
ity. Retention rates were high (>90% at all time points). We fol-
lowed a published trial protocol15 and statistical analysis plan.18
Data were collected and analyzed by researchers who were
masked to group allocation.
We used PICKUP, a validated prognosis model,8 to ex-
clude people with acute low back pain who were at lower than
average risk of pain chronicity. Approximately 40% of in-
cluded participants developed chronic low back pain, a rate
twice that of other trials on acute low back pain conducted in
the same geographical area of Sydney (approximately
15%-20%).9,27 We are therefore confident that we included par-
ticipants who were at high risk of pain chronicity.
This study also has limitations. First, trial clinicians could
not be blinded to treatment allocation. However, results of our
audit suggested that there were no systematic differences in
treatment credibility or treatment fidelity. Second, interven-
tions in the PREVENT trial15 were provided by trial physio-
therapists, and it is unclear whether our results would have
been the same if the participant’s health practitioner pro-
vided the intervention. Third, we performed a number of sta-
tistical comparisons, which although planned, increased the
Table 3. Secondary Outcomes for the Patient Education and Placebo Patient Education Groups at 1 Week







Difference or OR (95% CI) P Value
Chronic low back pain at 3 mo,
No./total No. (%)b
33/96 (34.4) 42/93 (45.1) 0.63 (0.32 to 1.14) .13
Disabilityc
1 wk 5.6 (5.2) 7.1 (5.8) −1.6 (−3.1 to −0.1) .03
3 mo 3.5 (4.6) 4.9 (6.0) −1.7 (−3.2 to −0.2) .03
6 mo 3.8 (5.2) 4.3 (5.2) −0.8 (−2.4 to 0.7) .28
12 mo 3.0 (4.7) 3.8 (5.1) −0.8 (−2.4 to 0.7) .29
Overall intervention effectd NA NA NA .17
Pain interferencee
1 wk 2.8 (2.7) 2.9 (2.5) −0.1 (−0.8 to 0.6) .71
3 mo 1.5 (2.1) 2.3 (2.4) −0.8 (−1.5 to −0.1) .02
6 mo 1.8 (2.6) 1.9 (2.3) −0.1 (−0.8 to 0.6) .87
12 mo 1.6 (2.4) 2.0 (2.5) −0.4 (−1.1 to 0.3) .30
Overall intervention effectd NA NA NA .16
Depressive symptomsf
1 wk 2.6 (4.1) 3.3 (4.3) −0.7 (−1.8 to 0.5) .26
3 mo 2.1 (3.9) 2.5 (4.1) −0.5 (−1.7 to 0.6) .36
Overall intervention effectd NA NA NA .89
Current pain intensityg
1 wk 2.3 (2.1) 2.2 (2.1) 0.1 (−0.5 to 0.7) .69
3 mo 1.5 (2.0) 2.1 (2.1) −0.6 (−1.2 to −0) .04
6 mo 1.8 (2.5) 1.8 (1.9) −0.1 (−0.7 to 0.5) .78
12 mo 1.4 (2.1) 1.7 (2.1) −0.3 (−0.9 to 0.3) .33
Overall intervention effectd NA NA NA .13
Seeking health care for low back
pain, No./total No. (%)
3 mo 73/96 (76.0) 82/93 (88.2) 0.43 (0.19 to 0.93) .03
6 mo 44/95 (46.3) 48/91 (52.7) 0.77 (0.43 to 1.38) .38
12 mo 32/91 (35.2) 38/87 (43.7) 0.70 (0.38 to 1.28) .25
Global change at 3 moh 8.1 (1.7) 7.8 (2.0) −0.3 (−0.9 to 0.2) .11
Recurrence at 12 mo, No./
total No. (%)i
26/91 (28.6) 41/87 (47.1) 0.44 (0.24 to 0.82) .01
Pain attitudes
1 wk 1.3 (1.2) 2.2 (1.3) −0.9 (−1.2 to −0.5) <.001
12 mo 1.2 (1.2) 1.6 (1.3) −0.4 (−0.7 to 0) .03
Overall intervention effectd NA NA NA .16
Nothing seriously wrong
(0-10) at 1 wkj
7.6 (2.5) 6.5 (2.9) 1.2 (0.4 to 2.0) .003
Yes, perceive a need for
further tests at 1 wk, No./total
No. (%)
25/98 (25.5) 36/96 (37.5) 0.57 (0.31 to 1.05) .07
Abbreviations: NA, not applicable;
OR, odds ratio.
a Data are presented as mean (SD)
unless otherwise indicated.
b Reporting 2 or more on an 11-point
pain intensity numeric rating scale
during the past week and no periods
of recovery at that time.
c Roland Morris Disability
Questionnaire with range from 0
(no disability) to 24 (high disability).
d P value is from mixed models for
repeated measures comparing
between-group difference during
the full 12-month trial, controlling
for baseline and including time
points as a categorical variable.
e Numeric rating scale with range
from 0 (no interference) to 10
(highest interference possible).
f Depression severity scale of
Depression, Anxiety, and Stress
Scale with range from 0 (no
depressive symptoms) to 42 (high
depressive symptoms).
g Numeric rating scale with range
from 0 (no pain) to 10 (worst pain
possible).
h Global Back Recovery Scale.
i Recurrence was defined as
answering yes to both of the
following questions: (1) “In the last 6
months/12 months, has your lower
back pain gone away completely for
a period of more than 30 days, only
to return later on?” and (2) “If yes,
did the return of low back pain last
at least 24 hours with a pain
intensity of more than 2/10?”
j “How reassured do you feel that
there is no serious condition causing
your back pain?” Range from 0 (not
reassured at all) to 10 (completely
reassured).
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risk of Type I error. Interpretation of the statistically signifi-
cant effects of intensive patient education on some second-
ary outcomes, such as pain interference and recurrence and
odds of seeking health care (Table 3), must consider this po-
tential limitation. Finally, because both groups received ba-
sic patient education as part of recommended first-line care
and many recovered despite being classified as being high risk,
the potential for between-group differences may have been
reduced.
Conclusions
For patients with acute low back pain who received first-line
care, intensive patient education was no more effective
than a placebo intervention. Adding complex, time-
consuming treatments to primary-care based advice and
reassurance is likely to be unnecessary for most patients
with acute low back pain.
ARTICLE INFORMATION
Accepted for Publication: August 24, 2018.
Published Online: November 5, 2018.
doi:10.1001/jamaneurol.2018.3376
Author Affiliations: Neuroscience Research
Australia, Sydney, New South Wales, Australia
(Traeger, Lee, Hübscher, Skinner, Moseley,
McAuley); Sydney School of Public Health, Faculty
of Medicine and Health, The University of Sydney,
Sydney, New South Wales, Australia (Traeger,
Henschke); Centre for Statistics in Medicine,
Nuffield Department of Orthopaedics,
Rheumatology and Musculoskeletal Sciences,
University of Oxford, Oxford, United Kingdom
(Lee); Graduate School of Health, University of
Technology, Sydney, New South Wales, Australia
(Skinner); Sansom Institute for Health Research,
University of South Australia, Adelaide, South
Australia, Australia (Moseley); University of Sydney
at Royal North Shore Hospital, Pain Management
Research Institute, Sydney, New South Wales,
Australia (Nicholas); Faculty of Health Sciences, The
University of Sydney, Sydney, New South Wales,
Australia (Refshauge); Centre for Education and
Research on Ageing, The University of Sydney,
Sydney, New South Wales, Australia (Blyth);
Arthritis Care UK National Primary Care Centre,
Keele University, North Staffordshire, United
Kingdom (Main); Department of Health
Professions, Macquarie University, Sydney, New
South Wales, Australia (Hush); Melanoma Institute
Australia, The University of Sydney, Sydney, New
South Wales, Australia (Lo); Institute for Research
and Medical Consultations, University of Dammam,
Dammam, Kingdom of Saudi Arabia (Lo); Exercise
Physiology, School of Medical Sciences, Faculty of
Medicine, University of New South Wales, Sydney,
New South Wales, Australia (McAuley).
Author Contributions: Drs Traeger and McAuley
had full access to all the data in the study and take
responsibility for the integrity of the data and the
accuracy of the data analysis.
Concept and design: Traeger, Lee, Hübscher,
Moseley, Nicholas, Henschke, Refshauge, Blyth,
Main, McAuley.
Acquisition, analysis, or interpretation of data:
Traeger, Lee, Hübscher, Skinner, Moseley, Nicholas,
Henschke, Refshauge, Blyth, Hush, Lo, McAuley.
Drafting of the manuscript: Traeger, Lee, Hübscher,
Skinner, Refshauge, Hush, McAuley.
Critical revision of the manuscript for important
intellectual content: All authors.
Statistical analysis: Traeger, Lee, Skinner, Lo,
McAuley.
Obtained funding: Moseley, Nicholas, Refshauge,
McAuley.
Administrative, technical, or material support:
Traeger, Lee, Skinner, Nicholas, McAuley.
Supervision: Hübscher, Moseley, Nicholas,
Henschke, Refshauge, McAuley.
Conflict of Interest Disclosures: Prof Moseley
reported receiving author royalties for books
entitled Explain Pain. No other disclosures were
reported.
Funding/Support: The Australian National Health
and Medical Research Council funded this trial
(project identification number: 1047827), which
was investigator initiated (chief investigator, Prof
McAuley; coinvestigators, Dr Henschke and Prof
Nicholas, Moseley, Main, Blyth, and Refshauge).
Dr Traeger, Dr Lee, and Prof Moseley were
supported by National Health and Medical Research
Council research fellowships.
Role of the Funder/Sponsor: The funding
organizations had no role in the design and conduct
of the study; collection, management, analysis, and
interpretation of the data; preparation, review, or
approval of the manuscript; and decision to submit
the manuscript for publication.
Additional Contributions: The staff of primary care
practices in Sydney, Australia, recruited participants
for the trial and were reimbursed per participant for
time spent on the study. Chris Maher, PhD, The
University of Sydney, gave his advice on early
versions of the manuscript. We acknowledge the
invaluable contribution of Garry Pearce, MBBS, MD,
who died in 2017. Prof Maher and Dr Pearce were
not financially compensated for their contributions.
Data Sharing Statement: See Supplement 3.
REFERENCES
1. GBD 2016 Disease and Injury Incidence and
Prevalence Collaborators. Global, regional, and
national incidence, prevalence, and years lived with
disability for 328 diseases and injuries for 195
countries, 1990-2016: a systematic analysis for the
Global Burden of Disease Study 2016. Lancet. 2017;
390(10100):1211-1259. doi:10.1016/S0140-6736(17)
32154-2
2. Deyo RA, Weinstein JN. Low back pain. N Engl J
Med. 2001;344(5):363-370. doi:10.1056
/NEJM200102013440508
3. Hartvigsen J, Hancock MJ, Kongsted A, et al;
Lancet Low Back Pain Series Working Group. What
low back pain is and why we need to pay attention.
Lancet. 2018;391(10137):2356-2367. doi:10.1016
/S0140-6736(18)30480-X
4. Foster NE, Anema JR, Cherkin D, et al; Lancet
Low Back Pain Series Working Group. Prevention
and treatment of low back pain: evidence,
challenges, and promising directions. Lancet. 2018;
391(10137):2368-2383. doi:10.1016/S0140-6736(18)
30489-6
5. Buchbinder R, van Tulder M, Öberg B, et al;
Lancet Low Back Pain Series Working Group. Low
back pain: a call for action. Lancet. 2018;391(10137):
2384-2388. doi:10.1016/S0140-6736(18)30488-4
6. Traeger A, Buchbinder R, Harris I, Maher C.
Diagnosis and management of low-back pain in
primary care. CMAJ. 2017;189(45):E1386-E1395.
doi:10.1503/cmaj.170527
7. da Silva T, Mills K, Brown BT, Herbert RD, Maher
CG, Hancock MJ. Risk of recurrence of low back
pain: a systematic review. J Orthop Sports Phys Ther.
2017;47(5):305-313. doi:10.2519/jospt.2017.7415
8. Traeger AC, Henschke N, Hübscher M, et al.
Estimating the risk of chronic pain: development
and validation of a prognostic model (PICKUP) for
patients with acute low back pain. PLoS Med. 2016;
13(5):e1002019. doi:10.1371/journal.pmed.1002019
9. Hancock MJ, Maher CG, Latimer J, et al.
Assessment of diclofenac or spinal manipulative
therapy, or both, in addition to recommended
first-line treatment for acute low back pain:
a randomised controlled trial. Lancet. 2007;370
(9599):1638-1643. doi:10.1016/S0140-6736(07)
61686-9
10. Machado LA, Maher CG, Herbert RD, Clare H,
McAuley JH. The effectiveness of the McKenzie
method in addition to first-line care for acute low
back pain: a randomized controlled trial. BMC Med.
2010;8:10. doi:10.1186/1741-7015-8-10
11. Eisenberg DM, Post DE, Davis RB, et al. Addition
of choice of complementary therapies to usual care
for acute low back pain: a randomized controlled
trial. Spine (Phila Pa 1976). 2007;32(2):151-158. doi:
10.1097/01.brs.0000252697.07214.65
12. Engers A, Jellema P, Wensing M, van der Windt
DA, Grol R, van Tulder MW. Individual patient
education for low back pain. Cochrane Database
Syst Rev. 2008;(1):CD004057. doi:10.1002
/14651858.CD004057.pub3
13. Koes BW, van Tulder M, Lin CW, Macedo LG,
McAuley J, Maher C. An updated overview of
clinical guidelines for the management of
non-specific low back pain in primary care. Eur
Spine J. 2010;19(12):2075-2094. doi:10.1007
/s00586-010-1502-y
14. Louw A, Zimney K, Puentedura EJ, Diener I.
The efficacy of pain neuroscience education on
musculoskeletal pain: a systematic review of the
literature. Physiother Theory Pract. 2016;32(5):332-
355. doi:10.1080/09593985.2016.1194646
15. Traeger AC, Moseley GL, Hübscher M, et al. Pain
education to prevent chronic low back pain: a study
protocol for a randomised controlled trial. BMJ Open.
2014;4(6):e005505. doi:10.1136/bmjopen-2014
-005505
16. Butler DS, Moseley GL. Explain Pain. 2nd ed.
Adelaide, South Australia: Noigroup Publications;
2013.
Research Original Investigation Effect of Intensive Patient Education on Pain Outcomes in Patients With Acute Low Back Pain
E8 JAMA Neurology Published online November 5, 2018 (Reprinted) jamaneurology.com
© 2018 American Medical Association. All rights reserved.
Downloaded From:  by Ian Skinner on 11/05/2018
17. Devilly GJ, Borkovec TD. Psychometric
properties of the credibility/expectancy
questionnaire. J Behav Ther Exp Psychiatry. 2000;
31(2):73-86. doi:10.1016/S0005-7916(00)00012-4
18. Traeger AC, Skinner IW, Hübscher M, et al. A
randomized, placebo-controlled trial of patient
education for acute low back pain (PREVENT Trial):
statistical analysis plan. Braz J Phys Ther. 2017;21(3):
219-223. doi:10.1016/j.bjpt.2017.04.005
19. Lee H, Moseley GL, Hübscher M, et al.
Understanding how pain education causes changes
in pain and disability: protocol for a causal
mediation analysis of the PREVENT trial. J Physiother.
2015;61(3):156. doi:10.1016/j.jphys.2015.03.004
20. Nicholas MK, Asghari A, Blyth FM. What do the
numbers mean? normative data in chronic pain
measures. Pain. 2008;134(1-2):158-173. doi:10.1016
/j.pain.2007.04.007
21. Hill JC, Whitehurst DG, Lewis M, et al.
Comparison of stratified primary care management
for low back pain with current best practice (STarT
Back): a randomised controlled trial. Lancet. 2011;
378(9802):1560-1571. doi:10.1016/S0140-6736(11)
60937-9
22. National Institute for Health and Care
Excellence (NICE). Clinical Guidelines. Low Back
Pain and Sciatica in Over 16s: Assessment and
Management. London: National Institute for Health
and Care Excellence; 2016.
23. Qaseem A, Wilt TJ, McLean RM, Forciea MA;
Clinical Guidelines Committee of the American
College of Physicians. Noninvasive treatments for
acute, subacute, and chronic low back pain:
a clinical practice guideline from the American
College of Physicians. Ann Intern Med. 2017;166(7):
514-530. doi:10.7326/M16-2367
24. Stevens ML, Lin CC, de Carvalho FA, Phan K,
Koes B, Maher CG. Advice for acute low back pain:
a comparison of what research supports and what
guidelines recommend. Spine J. 2017;17(10):1537-
1546. doi:10.1016/j.spinee.2017.05.030
25. Traeger AC, Hübscher M, Henschke N, Moseley
GL, Lee H, McAuley JH. Effect of primary
care-based education on reassurance in patients
with acute low back pain: systematic review and
meta-analysis. JAMA Intern Med. 2015;175(5):733-
743. doi:10.1001/jamainternmed.2015.0217
26. Chou R. Reassuring patients about low back
pain. JAMA Intern Med. 2015;175(5):743-744. doi:10
.1001/jamainternmed.2015.0252
27. Williams CM, Maher CG, Latimer J, et al.
Efficacy of paracetamol for acute low-back pain:
a double-blind, randomised controlled trial. Lancet.
2014;384(9954):1586-1596. doi:10.1016/S0140-6736
(14)60805-9
Effect of Intensive Patient Education on Pain Outcomes in Patients With Acute Low Back Pain Original Investigation Research
jamaneurology.com (Reprinted) JAMA Neurology Published online November 5, 2018 E9
© 2018 American Medical Association. All rights reserved.
Downloaded From:  by Ian Skinner on 11/05/2018
